Diagnostic pill that can be swallowed
12/06/2013
A tiny capsule that can carry out a chemical analysis of the contents of one's stomach could identify the presence of so-called "occult" blood at very low levels. The data is automatically broadcast to an external monitoring device for detection of early stage stomach cancer by one's physician.
Tumor suppressor turned into anti-cancer target
12/06/2013
The laboratory of Marcos Malumbres, who is head of the Spanish National Cancer Research Centre's (CNIO) Cell Division & Cancer Group, working alongside Isabel Farinas' team from the University of Valencia, shows, in a study published in the journal Nature Communications, how in mice the elimination of the Cdh1 protein - a sub-unit of the APC/C complex, involved in the control of cell division ...
Improved screening methods likely following new insights into Barrett's esophagus, cancer evolution
12/06/2013
A new appreciation of how cancer cells evolve could help scientists design better screening methods to catch cancer before it advances.
Researchers unravel important role of Rb tumor suppressor in aggressive form of breast cancer
12/06/2013
The retinoblastoma (Rb) protein plays a critical role in suppressing the multi-step process of cell migration through the bloodstream, lymphovascular invasion and the metastasis of an aggressive type of breast cancer to the lung, researchers at the University of Cincinnati (UC) Cancer Institute, the Cincinnati Cancer Center (CCC) and the UC Brain Tumor Center have found.
Counting tumor-attacking immune cells to predict ovarian cancer survival
12/06/2013
One way to predict survival of many types of cancer is by counting the number of tumor-attacking immune cells that have migrated into the tumor in an effort to eradicate it - a sign of the body's immune response to the cancer. However, quantifying these armies of immune cells has been difficult - until now.
Cancer mutation likely trigger of scleroderma
12/05/2013
Johns Hopkins scientists have found evidence that cancer triggers the autoimmune disease scleroderma, which causes thickening and hardening of the skin and widespread organ damage.A report on the discovery, published in the Dec. 5 issue of Science, also suggests that a normal immune system is critical for preventing the development of common types of cancer.
New guidelines stress importance of vaccinating immunocompromised patients
12/05/2013
People with compromised immune systems - such as those with cancer, HIV infection and Crohn's disease - are especially vulnerable to illness and most should receive the flu shot and other vaccinations, notes a new guideline released by the Infectious Diseases Society of America (IDSA).
The American Society of Hematology (ASH), the world's largest professional organization dedicated to the causes and treatments of blood disorders, today released a list of common hematology tests, treatments, and procedures that are not always necessary as part of Choosing Wisely®, an initiative of the ABIM Foundation.
Targeting evolving cancer stem cells in prostate cancer
12/05/2013
UCLA researchers have discovered how prostate cancer stem cells evolve as the disease progresses, a finding that could help point the way to more highly targeted therapies.
Increased cancer risk signaled by protein in prostate biopsies
12/05/2013
Researchers from Weill Cornell Medical College have shown that the presence of a particular protein in biopsied prostate tissue substantially increases the likelihood that cancer will develop in that organ. The discovery will likely help physicians decide how closely to monitor men potentially at risk for the cancer -- among the most confusing and controversial dilemmas in health care.